BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25394212)

  • 1. Use of infliximab in toxic epidermal necrolysis: a still opened challenge.
    Ganzetti G; Campanati A; Simonetti O; Giuliodori K; Giangiacomi M; Lemme G; Offidani A
    G Ital Dermatol Venereol; 2015 Aug; 150(4):467-71. PubMed ID: 25394212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric toxic epidermal necrolysis treated successfully with infliximab.
    Chafranska L; Saunte DM; Behrendt N; Nygaard U; Christensen RJ; Sand C; Jemec GB
    Pediatr Dermatol; 2019 May; 36(3):342-345. PubMed ID: 30834560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Toxic Epidermal Necrolysis.
    Harris V; Jackson C; Cooper A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
    Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE
    Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab.
    Kreft B; Wohlrab J; Bramsiepe I; Eismann R; Winkler M; Marsch WC
    J Dermatol; 2010 Oct; 37(10):904-6. PubMed ID: 20860742
    [No Abstract]   [Full Text] [Related]  

  • 6. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis.
    Woolridge KF; Boler PL; Lee BD
    Cutis; 2018 Jan; 101(1):E15-E21. PubMed ID: 29529123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive hypertrophic scarring after toxic epidermal necrolysis in a child.
    Kreft B; Lieser U; Haase R; Marsch WC; Wohlrab J
    Pediatr Dermatol; 2014; 31(4):527-8. PubMed ID: 23025572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Kaur-Knudsen D; Zachariae C; Thomsen SF
    Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management.
    Dalli RL; Kumar R; Kennedy P; Maitz P; Lee S; Johnson R
    ANZ J Surg; 2007 Aug; 77(8):671-6. PubMed ID: 17635282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Khalili B; Bahna SL
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fatal case of sulindac-induced Lyell syndrome (toxic epidermal necrolysis).
    Ikeda N; Umetsu K; Suzuki T
    Z Rechtsmed; 1987; 98(2):141-6. PubMed ID: 3604469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Koh MJ; Tay YK
    Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.